Australian researchers developed weekly injectable gel for Parkinson's

A new weekly injectable gel delivers Parkinson's medication, potentially replacing daily pills and improving patient outcomes. This could significantly improve the lives of millions. The biodegradable gel, developed by Australian researchers, provides a steady dose of levodopa and carbidopa for seven days after a single injection. This aims to reduce tremors and stiffness while minimizing side effects associated with fluctuating medication levels. The innovation, which has been filed for an Australian patent, could also be adapted for other chronic conditions. Researchers hope to begin clinical trials soon and are exploring commercialization opportunities for this promising treatment.